Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta

View ORCID ProfileNicholas Barasch, View ORCID ProfileJameel Iqbal, Marvin Coombs, Sofia Kazi, Jessica Wang-Rodriguez, Mark Holodniy, Michael Gelman
doi: https://doi.org/10.1101/2021.12.22.21268195
Nicholas Barasch
1James J. Peters Veterans Affairs Medical Center, Bronx, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas Barasch
  • For correspondence: nicholas.barasch{at}va.gov
Jameel Iqbal
2DaVita Labs, DeLand, FL
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jameel Iqbal
Marvin Coombs
1James J. Peters Veterans Affairs Medical Center, Bronx, NY
MPH MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofia Kazi
1James J. Peters Veterans Affairs Medical Center, Bronx, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Wang-Rodriguez
3National Pathology and Laboratory Medicine, Veterans Health Administration, Washington, DC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Holodniy
4Office of Public Health, Veterans Health Administration, Washington, DC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Gelman
1James J. Peters Veterans Affairs Medical Center, Bronx, NY
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.12.22.21268195
History 
  • December 27, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Nicholas Barasch, MD1,*,
  2. Jameel Iqbal, MD PhD2,
  3. Marvin Coombs, MPH MBA1,
  4. Sofia Kazi, MD1,
  5. Jessica Wang-Rodriguez, MD3,
  6. Mark Holodniy, MD4 and
  7. Michael Gelman, MD PhD1
  1. 1James J. Peters Veterans Affairs Medical Center, Bronx, NY
  2. 2DaVita Labs, DeLand, FL
  3. 3National Pathology and Laboratory Medicine, Veterans Health Administration, Washington, DC
  4. 4Office of Public Health, Veterans Health Administration, Washington, DC
  1. ↵*(Corresponding Author); email: nicholas.barasch{at}va.gov
Back to top
PreviousNext
Posted December 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta
Nicholas Barasch, Jameel Iqbal, Marvin Coombs, Sofia Kazi, Jessica Wang-Rodriguez, Mark Holodniy, Michael Gelman
medRxiv 2021.12.22.21268195; doi: https://doi.org/10.1101/2021.12.22.21268195
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta
Nicholas Barasch, Jameel Iqbal, Marvin Coombs, Sofia Kazi, Jessica Wang-Rodriguez, Mark Holodniy, Michael Gelman
medRxiv 2021.12.22.21268195; doi: https://doi.org/10.1101/2021.12.22.21268195

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)